Particle.news

Download on the App Store

Studies Show Lymph Nodes Sustain Stem-Like T Cells That Power Cancer Immunotherapy

Researchers will test the findings in patient samples after publishing two preclinical Nature Immunology papers.

Overview

  • Two peer-reviewed Nature Immunology papers from a Doherty Institute-led team show lymph nodes sustain stem-like CD8+ T cells that seed cytotoxic responses to cancer and chronic infection.
  • The studies find these progenitors arise in nodes rather than tumors or spleen, underscoring a distinct microenvironment for their survival and expansion.
  • Molecular analysis identifies KLF2-linked pathways that drive effector differentiation during chronic infection and checkpoint blockade therapy.
  • Researchers suggest lymph-node removal in cancer surgery could blunt immunotherapies including checkpoint inhibitors and CAR T cells, noting this hypothesis requires clinical testing.
  • Planned next steps include analyzing samples from patients on immunotherapy through a Melanoma Research Victoria collaboration, with work conducted in animal models to date.